Skip to main content

Table 10 Total economic benefits of influenza immunisation to the school-age population

From: Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children

Influenza-associated costsNo influenza immunisationInfluenza immunisationCosts avoided
Direct costs
 Laboratory diagnosis259,878,840246,608,19313,270,647
 Medical consultations266,216,669251,638,14414,578,525
 Drugs43,978,88041,388,9862,589,893
 Hospitalisations1,866,950,8451,773,439,65193,511,195
 Influenza immunisation to school-aged population 27,421,602−27,421,602
Total direct costs (third-party payer perspective)2,437,025,2332,340,496,57796,528,657
Indirect costs
 Productivity loss267,469,325253,037,89614,431,429
 Premature death29,368,24028,338,8581,029,382
 Total indirect costs296,837,565281,376,75515,460,811
Total costs of influenza (societal perspective)2,733,862,7992,621,873,331111,989,467
  1. All costs are in USD
\